Clarivate Launches Derwent Patent Monitor to Enable Fast and Accurate Decision-making with AI
New enterprise solution streamlines IP and R&D patent reviews and accelerates freedom to operate, patentability, and infringement related decisions LONDON, Nov. 24, 2025 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a leading global provider of...
Fujifilm Selects IPfolio from Clarivate
Maximizing the value of intellectual property assets to support business growth LONDON, Nov. 6, 2025 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, announced today that FUJIFILM Holdings...
Clarivate Unveils the 2025 Journal Citation Reports
50th Anniversary Year Sees Strengthened Focus on Research Integrity LONDON, June 18, 2025 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, today released the 2025 update to the Journal Citation...
Clarivate Identifies Radioligand Therapy Innovators as Companies to Watch in the Future of Precision Oncology
New Report Highlights Emerging Leaders Advancing Next-generation Radiopharmaceuticals, Reshaping Cancer Care Through Targeted Innovation and Strategic Growth LONDON, June 16, 2025 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a leading global provider...
Clarivate Partners with American Library Association to Advocate for U.S. Libraries
LONDON, June 9, 2025 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, today announced a new milestone in its decades-long partnership with the American Library Association (ALA). Clarivate will be...
Clarivate Partners with CRKN to Further Canada's Research Goals
Web of Science Provides Expanded Access to Essential Research Tools and Data for Canadian Libraries and Research Institutions LONDON, June 3, 2025 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence,...
Clarivate and CAPES Expand Landmark Partnership to Power Research and Innovation Across Brazil
New five-year agreement delivers critical academic and life sciences insights into more than 400 institutions, broadening access and driving national research excellence LONDON, June 2, 2025 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a leading...
Clarivate Launches AI-based RiskMark to Accelerate Trademark Conflict Assessments
New AI-based solution empowers trademark professionals to evaluate trademark risk and generate evidence-backed arguments with speed, ease, and confidence LONDON, May 19, 2025 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a leading global provider of...
Clarivate Enhances OFF-X with Pathway Maps to Accelerate Target Safety Assessments
R&D teams can streamline safety evaluations, reduce risks and enable faster decision-making in drug development using new visual and data-driven insights LONDON, May 14, 2025 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a leading global provider...
Clarivate Launches DRG Commercial Analytics 360 Enabling Medtech Companies to Advance Commercial Strategy and Execution
New solution provides integrated provider intelligence and real-world data to optimize targeting, strategic planning and patient access across commercial organizations LONDON, April 23, 2025 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a leading...